Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-9274

Beck-Schimmer, B; Breitenstein, S; Urech, S; De Conno, E; Wittlinger, M; Puhan, M; Jochum, W; Spahn, D R; Graf, R; Clavien, P A (2008). A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Annals of Surgery, 248(6):909-918.

[img]
Preview
Accepted Version
PDF
1MB
[img] PDF - Registered users only
1MB

Abstract

OBJECTIVE: To evaluate the effects of pharmacological preconditioning with a volatile anesthetic in patients undergoing liver resection with inflow occlusion. BACKGROUND: In liver surgery, ischemic preconditioning and intermittent clamping are the only established protective strategies to reduce tissue damage due to ischemia during inflow occlusion. Preconditioning with volatile anesthetics has provided protection against cardiac and renal ischemic injury in several animal models through NO and HO-1 pathways. But pharmacological preconditioning has never been tested in patients undergoing liver surgery in a randomized trial. METHODS: Sixty-four patients undergoing liver surgery with inflow occlusion were randomized intraoperatively for preconditioning with sevoflurane or not (ClinicalTrials.gov NCT00516711). Anesthesia was performed intravenously with propofol. Thirty minutes before inflow occlusion propofol was replaced by sevoflurane in the preconditioning group. Primary endpoint was postoperative liver injury assessed by peak values of liver transaminases. Postoperative complications were recorded according to an established scoring system. RESULTS: Sevoflurane preconditioning significantly limited the postoperative increase of serum transaminase levels by 261 U/L (95% CI, 65 to 458; P = 0.01) for the ALT and by 239 (95% CI, -2 to 480; P = 0.05) for the AST corresponding to decreases of baseline levels of 35% and 31%, respectively. Patients with steatosis had an even better benefit than patients without steatosis. The rates of any complication (risk ratio 0.46; 95% CI, 0.25 to 0.85; P = 0.006) and of severe complications requiring invasive procedures (risk ratio 0.25; 95% CI, 0.06 to 1.08; P = 0.05) were also lowered by preconditioning. CONCLUSION: This first randomized trial of pharmacological preconditioning in liver surgery in humans showed a protective effect of preconditioning with volatile anesthetics. This strategy may provide a new and easily applicable therapeutic option to protect the liver and to lower complication rates.

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > The Horten-Center for Applied Research and Science
04 Faculty of Medicine > Center for Integrative Human Physiology
04 Faculty of Medicine > University Hospital Zurich > Institute of Anesthesiology
04 Faculty of Medicine > Institute of Physiology
07 Faculty of Science > Institute of Physiology
DDC:570 Life sciences; biology
610 Medicine & health
Language:English
Date:2008
Deposited On:07 Jan 2009 09:40
Last Modified:27 Nov 2013 16:58
Publisher:Lippincott Wiliams & Wilkins
ISSN:0003-4932
Publisher DOI:10.1097/SLA.0b013e31818f3dda
PubMed ID:19092335
Citations:Web of Science®. Times Cited: 78
Google Scholar™
Scopus®. Citation Count: 87

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page